Heron Therapeutics, Inc. · NASDAQ:HRTX
Forbes William P exercised options for 3,874 Heron Therapeutics, Inc. shares (Form 4)
Traded Oct 19, 2026 · Filed Oct 21, 2026
On Oct 19, 2026, Forbes William P (EVP, Chief Development Officer) exercised options for 3,874 Heron Therapeutics, Inc. shares, leaving 243,945 shares. Filed Oct 21, 2026 (Form 4).
- Options exercised
- 3,874 shares
- Holding after
- 243,945 shares
- Trading plan
- No
- Role
- EVP, Chief Development Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Oct 19, 2026 | Common Stock | Option exercise | 3,874 | 245,047 | Direct | |
| Oct 19, 2026 | Common Stock | Shares withheld for tax | 1,102 | US$0.36 | 243,945 | Direct |
Source
Download original · View original at SEC
Related
- Heron Therapeutics, Inc.
- Forbes William P
- Heron Therapeutics, Inc. shareholders
- Form 4 · Forbes William P · Aug 3, 2026
- Form 4 · Forbes William P · Jul 20, 2026
- Form 4 · Forbes William P · Jun 8, 2026
- Form 4 · Forbes William P · May 4, 2026
- Form 4 · Forbes William P · Apr 21, 2026
- Form 4 · Collard Craig A · Oct 21, 2026
- Form 4 · Duarte Ira · Oct 21, 2026
- Form 4 · Hensley Mark Earl · Aug 10, 2026
- Form 4 · Hensley Mark Earl · Aug 3, 2026
- Form 4 · Duarte Ira · Aug 3, 2026